| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.85▼ | 5.84▼ | 5.88▼ | 6.34▼ | 5.78▲ |
| MA10 | 5.86▼ | 5.95▼ | 6.04▼ | 6.14▼ | 5.63▲ |
| MA20 | 6.03▼ | 6.14▼ | 6.24▼ | 5.81▲ | 6.29▼ |
| MA50 | 6.23▼ | 6.41▼ | 6.26▼ | 5.74▲ | 7.95▼ |
| MA100 | 6.44▼ | 6.06▼ | 5.91▼ | 6.42▼ | 11.45▼ |
| MA200 | 6.09▼ | 5.72▲ | 5.56▲ | 7.70▼ | 17.20▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.011▼ | -0.032▼ | -0.066▼ | 0.048▲ | 0.107▲ |
| RSI | 28.706▼ | 31.505▼ | 35.139▼ | 49.272▼ | 43.923▼ |
| STOCH | 16.451▼ | 6.398▼ | 3.306▼ | 62.481 | 38.755 |
| WILL %R | -93.407▼ | -94.643▼ | -96.026▼ | -69.944 | -75.542▼ |
| CCI | -59.520 | -78.449 | -102.783▼ | -16.359 | 17.721 |
|
Monday, July 13, 2026 05:19 AM
Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, ...
|
|
Monday, July 13, 2026 04:26 AM
Detailed price information for Aligos Therapeutics Inc (ALGS-Q) from The Globe and Mail including charting and trades.
|
|
Friday, July 10, 2026 06:00 AM
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/07/26 | 5.93 | 5.96 | 5.805 | 5.835 | 46,469 |
| 14/07/26 | 6.33 | 6.45 | 5.97 | 6.105 | 102,514 |
| 13/07/26 | 6.41 | 6.58 | 6.16 | 6.36 | 167,671 |
| 10/07/26 | 6.84 | 6.85 | 6.34 | 6.62 | 109,230 |
| 09/07/26 | 6.68 | 7.08 | 6.52 | 6.77 | 194,613 |
| 08/07/26 | 5.92 | 6.93 | 5.88 | 6.73 | 394,443 |
| 07/07/26 | 5.91 | 6.30 | 5.5455 | 6.09 | 792,448 |
| 06/07/26 | 5.65 | 6.035 | 5.44 | 5.85 | 2,697,979 |
| 02/07/26 | 5.53 | 5.70 | 5.35 | 5.59 | 89,575 |
| 01/07/26 | 5.72 | 5.81 | 5.44 | 5.45 | 67,279 |
|
|
||||
|
|
||||
|
|